2
|
Zhou X, Fan X, Mustafi D, Pineda F, Markiewicz E, Zamora M, Sheth D, Olopade OI, Oto A, Karczmar GS. Comparison of DCE-MRI of murine model cancers with a low dose and high dose of contrast agent. Phys Med 2021; 81:31-39. [PMID: 33373779 DOI: 10.1016/j.ejmp.2020.11.023] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/21/2020] [Revised: 10/27/2020] [Accepted: 11/19/2020] [Indexed: 02/08/2023] Open
Abstract
There are increasing concerns regarding intracellular accumulation of gadolinium (Gd) after multiple dynamic contrast enhanced (DCE) MRI scans. We investigated whether a low dose (LD) of Gd-based contrast agent is as effective as a high dose (HD) for quantitative analysis of DCE-MRI data, and evaluated the use of a split dose protocol to obtain new diagnostic parameters. Female C3H mice (n = 6) were injected with mammary carcinoma cells in the hind leg. MRI experiments were performed on 9.4 T scanner. DCE-MRI data were acquired with 1.5 s temporal resolution before and after a LD (0.04 mmol/kg), then again after 30 min followed by a HD (0.2 mmol/kg) bolus injection of Omniscan. The standard Tofts model was used to extract physiological parameters (Ktrans and ve) with the arterial input function derived from muscle reference tissue. In addition, an empirical mathematical model was used to characterize maximum contrast agent uptake (A), contrast agent uptake rate (α) and washout rate (β and γ). There were moderate to strong correlations (r = 0.69-0.97, p < 0001) for parameters Ktrans, ve, A, α and β from LD versus HD data. On average, tumor parameters obtained from LD data were significantly larger (p < 0.05) than those from HD data. The parameter ratios, Ktrans, ve, A and α calculated from the LD data divided by the HD data, were all significantly larger than 1.0 (p < 0.003) for tumor. T2* changes following contrast agent injection affected parameters calculated from HD data, but this was not the case for LD data. The results suggest that quantitative analysis of LD data may be at least as effective for cancer characterization as quantitative analysis of HD data. In addition, the combination of parameters from two different doses may provide useful diagnostic information.
Collapse
Affiliation(s)
- Xueyan Zhou
- School of Technology, Harbin University, Harbin, China; Department of Radiology, The University of Chicago, Chicago, IL 60637, United States
| | - Xiaobing Fan
- Department of Radiology, The University of Chicago, Chicago, IL 60637, United States
| | - Devkumar Mustafi
- Department of Radiology, The University of Chicago, Chicago, IL 60637, United States
| | - Federico Pineda
- Department of Radiology, The University of Chicago, Chicago, IL 60637, United States
| | - Erica Markiewicz
- Department of Radiology, The University of Chicago, Chicago, IL 60637, United States
| | - Marta Zamora
- Department of Radiology, The University of Chicago, Chicago, IL 60637, United States
| | - Deepa Sheth
- Department of Radiology, The University of Chicago, Chicago, IL 60637, United States
| | | | - Aytekin Oto
- Department of Radiology, The University of Chicago, Chicago, IL 60637, United States
| | - Gregory S Karczmar
- Department of Radiology, The University of Chicago, Chicago, IL 60637, United States.
| |
Collapse
|
8
|
Bae J, Zhang J, Wadghiri YZ, Minhas AS, Poptani H, Ge Y, Kim SG. Measurement of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging with reduced scan time. Magn Reson Med 2018; 80:1686-1696. [PMID: 29508443 DOI: 10.1002/mrm.27145] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2017] [Revised: 02/01/2018] [Accepted: 02/02/2018] [Indexed: 02/04/2023]
Abstract
PURPOSE To investigate the feasibility of measuring the subtle disruption of blood-brain barrier (BBB) using DCE-MRI with a scan duration shorter than 10 min. METHODS The extended Patlak-model (EPM) was introduced to include the effect of plasma flow (Fp ) in the estimation of vascular permeability-surface area product (PS). Numerical simulation studies were carried out to investigate how the reduction in scan time affects the accuracy in estimating contrast kinetic parameters. DCE-MRI studies of the rat brain were conducted with Fisher rats to confirm the results from the simulation. Intracranial F98 glioblastoma models were used to assess areas with different levels of permeability. In the normal brain tissues, the Patlak model (PM) and EPM were compared, whereas the 2-compartment-exchange-model (TCM) and EPM were assessed in the peri-tumor and the tumor regions. RESULTS The simulation study results demonstrated that scan time reduction could lead to larger bias in PS estimated by PM (>2000%) than by EPM (<47%), especially when Fp is low. When Fp was high as in the gray matter, the bias in PM-PS (>900%) were larger than that in EPM-PS (<42%). The animal study also showed similar results, where the PM parameters were more sensitive to the scan duration than the EPM parameters. It was also demonstrated that, in the peri-tumor region, the EPM parameters showed less change by scan duration than the TCM parameters. CONCLUSION The results of this study suggest that EPM can be used to measure PS with a scan duration of 10 min or less.
Collapse
Affiliation(s)
- Jonghyun Bae
- Sackler Institute of Graduate Biomedical Science, New York University School of Medicine, New York, New York.,Bernard and Irene Schwartz Center for Biomedical Imaging, Radiology, New York University School of Medicine, New York, New York.,Center for Advanced Imaging Innovation and Research, Radiology, New York University School of Medicine, New York, New York
| | - Jin Zhang
- Bernard and Irene Schwartz Center for Biomedical Imaging, Radiology, New York University School of Medicine, New York, New York.,Center for Advanced Imaging Innovation and Research, Radiology, New York University School of Medicine, New York, New York
| | - Youssef Zaim Wadghiri
- Bernard and Irene Schwartz Center for Biomedical Imaging, Radiology, New York University School of Medicine, New York, New York.,Center for Advanced Imaging Innovation and Research, Radiology, New York University School of Medicine, New York, New York
| | - Atul Singh Minhas
- Centre for Preclinical Imaging, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
| | - Harish Poptani
- Centre for Preclinical Imaging, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom
| | - Yulin Ge
- Bernard and Irene Schwartz Center for Biomedical Imaging, Radiology, New York University School of Medicine, New York, New York.,Center for Advanced Imaging Innovation and Research, Radiology, New York University School of Medicine, New York, New York
| | - Sungheon Gene Kim
- Bernard and Irene Schwartz Center for Biomedical Imaging, Radiology, New York University School of Medicine, New York, New York.,Center for Advanced Imaging Innovation and Research, Radiology, New York University School of Medicine, New York, New York
| |
Collapse
|
9
|
You SH, Choi SH, Kim TM, Park CK, Park SH, Won JK, Kim IH, Lee ST, Choi HJ, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH. Differentiation of High-Grade from Low-Grade Astrocytoma: Improvement in Diagnostic Accuracy and Reliability of Pharmacokinetic Parameters from DCE MR Imaging by Using Arterial Input Functions Obtained from DSC MR Imaging. Radiology 2017; 286:981-991. [PMID: 29244617 DOI: 10.1148/radiol.2017170764] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Purpose To evaluate whether arterial input functions (AIFs) derived from dynamic susceptibility-contrast (DSC) magnetic resonance (MR) imaging, or AIFDSC values, improve diagnostic accuracy and reliability of the pharmacokinetic (PK) parameters of dynamic contrast material-enhanced (DCE) MR imaging for differentiating high-grade from low-grade astrocytomas, compared with AIFs obtained from DCE MR imaging (AIFDCE). Materials and Methods This retrospective study included 226 patients (138 men, 88 women; mean age, 52.27 years ± 15.17; range, 24-84 years) with pathologically confirmed astrocytomas (World Health Organization grade II = 21, III = 53, IV = 152; isocitrate dehydrogenase mutant, 11.95% [27 of 226]; 1p19q codeletion 0% [0 of 226]). All patients underwent both DSC and DCE MR imaging before surgery, and AIFDSC and AIFDCE were obtained from each image. Volume transfer constant (Ktrans), volume of vascular plasma space (vp), and volume of extravascular extracellular space (ve) were processed by using postprocessing software with two AIFs. The diagnostic accuracies of individual parameters were compared by using receiver operating characteristic curve (ROC) analysis. Intraclass correlation coefficients (ICCs) and the Bland-Altman method were used to assess reliability. Results The AIFDSC-driven mean Ktrans and ve were more accurate for differentiating high-grade from low-grade astrocytoma than those derived by using AIFDCE (area under the ROC curve: mean Ktrans, 0.796 vs 0.645, P = .038; mean ve, 0.794 vs 0.658, P = .020). All three parameters had better ICCs with AIFDSC than with AIFDCE (Ktrans, 0.737 vs 0.095; vp, 0.848 vs 0.728; ve, 0.875 vs 0.581, respectively). In AIF analysis, maximal signal intensity (0.837 vs 0.524) and wash-in slope (0.800 vs 0.432) demonstrated better ICCs with AIFDSC than AIFDCE. Conclusion AIFDSC-driven DCE MR imaging PK parameters showed better diagnostic accuracy and reliability for differentiating high-grade from low-grade astrocytoma than those derived from AIFDCE. © RSNA, 2017 Online supplemental material is available for this article.
Collapse
Affiliation(s)
- Sung-Hye You
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Seung Hong Choi
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Tae Min Kim
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Chul-Kee Park
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Sung-Hye Park
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Jae-Kyung Won
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Il Han Kim
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Soon Tae Lee
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Hye Jeong Choi
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Roh-Eul Yoo
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Koung Mi Kang
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Tae Jin Yun
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Ji-Hoon Kim
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| | - Chul-Ho Sohn
- From the Department of Radiology (S.H.Y., S.H.C., H.J.C., R.E.Y., K.M.K., T.J.Y., J.H.K., C.H.S.), Department of Internal Medicine (T.M.K.), Department of Radiation Oncology (I.H.K.), Cancer Research Institute, Department of Neurosurgery, Biomedical Research Institute (C.K.P.), Department of Pathology (S.H.P., J.K.W.) and Department of Neurology (S.T.L.), Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, 110-744 Seoul, Korea; Center for Nanoparticle Research, Institute for Basic Science (S.H.C.), and School of Chemical and Biological Engineering (S.H.C.), Seoul National University, Seoul, Korea
| |
Collapse
|